| Literature DB >> 32483427 |
Sicheng Zhang1,2,3,4, Yan Yang1,2,3,4, Sixun Jia1,2,3,4, Hong Chen1,2,3,4, Yufeng Duan1,2,3,4, Xuebing Li1,2,3,4, Shikai Wang1,2,3,4, Tao Wang1,2,3,4, Yun Lyu2,5, Guoqing Chen2,5, Weidong Tian1,2,3,4.
Abstract
Background: The formation of dentin-pulp involves complex epithelial-mesenchymal interactions between Hertwig's epithelial root sheath cells (HERS) and dental papilla cells (DPCs). Earlier studies have identified some of the regulatory molecules participating in the crosstalk between HERS and DPCs and the formation of dentin-pulp. In the present study we focused on the role of HERS-secreted exosomes in DPCs and the formation of dentin-pulp. Specifically, we hypothesized that exosome-like vesicles (ELVs) might mediate the function of HERS and trigger lineage-specific differentiation of dental mesenchymal cells. To test our hypothesis, we evaluated the potential of ELVs derived from a HERS cell line (ELVs-H1) in inducing in vitro and in vivo differentiation of DPCs.Entities:
Keywords: Hertwig's epithelial root sheath cell; epithelial-mesenchymal interaction; exosome-like vesicle; odontogenic differentiation; pulp-dentin regeneration.
Mesh:
Year: 2020 PMID: 32483427 PMCID: PMC7254987 DOI: 10.7150/thno.43156
Source DB: PubMed Journal: Theranostics ISSN: 1838-7640 Impact factor: 11.556
Figure 1Exosomal vesicles mediate interaction of HERS and DPCs cells (A) Schematic diagram showing transwell coculture of HERS-H1 and DPCs cells. (B) HERS-H1 cells were labeled by DiO (B i), DPCs cells were stained with phallotoxins, and nuclei were stained with DAPI (B ii). DPCs cells cocultured with HERS-H1 cells endocytosed exosomal vesicles (white arrow) released from HERS-H1 cells (B iii), whereas DPCs cells cocultured with GW4869-pretreated HERS-H1 cells did not show the endocytosed exosomal vesicles (B iv). (C) HERS-H1 cells upregulated the expression of DSPP and DMP1 in DPCs cells, which was attenuated by pretreatment with GW4869. (D) TEM analysis of ELVs. (E) DLS showed the particle size distribution of ELVs-H1. (F) Western blot analysis of the surface markers of ELVs. (G) DPCs cells were incubated with DiO-labeled ELVs (green) for 2, 24, and 48 h, respectively. Nuclei of DPCs cells were stained with DAPI (blue). (TEM: transmission electron microscope; DLS: dynamic light scattering). Scale bars are shown. *p < 0.05 vs. Con; #p < 0.05 vs HERS-H1.
Figure 2HERS-H1 cells-derived ELVs enhanced proliferation and migration of DPCs cells. (A) The proliferation of DPCs measured by the CCK8 assay. (B) Migrated cells per field of view from 4 different experiments. (C) Representative images of the capacity for cell migration shown by the transwell test. Scale bars represent 100 μm. *p < 0.05 vs. Con.
Figure 3HERS-H1 cells-derived ELVs enhanced odontogenic differentiation of DPC cells (A) Western blot analysis showing the significantly upregulated expression of odontoblastic markers (DSPP, DMP1, ALP, and RUNX2) in DPC cells after treatment with various concentrations of ELVs for 3 d. (B) ALP activity assay showing that treatment with ELVs increased the alkaline phosphatase activity of DPC cells with or without OM induction. (C) Representative images of Alizarin Red S staining showing that treatment with ELVs increased the odontogenic differentiation of DPC cells. (D) H&E staining showing that mineralized tissue was generated in the DPCs+ELVs group (black arrow). Immunohistochemical staining showing the upregulated expression of odontoblastic markers (OCN, DSPP, and DMP1) in the DPCs+ELVs group (white arrow). (OM: osteogenic medium; DSPP: dentin sialophosphoprotein; DMP1: dentin matrix protein 1; ALP: alkaline phosphatase; RUNX2: runt related transcription factor 2). Scale bars represent 50 μm. *p < 0.05 vs. Con.
Figure 4HERS-H1 cells-derived ELVs enhanced tube formation and neurogenic differentiation (A and B) In vitro tube formation of HUVECs and total number of nodes, meshes, and junctions of all tubing upregulated after treatment with ELVs (80 μg/mL). (C) Representative immunofluorescence images showing the increased expression of neurogenic differentiation markers (nestin and NF200) after treatment with ELVs (80 μg/mL) for 3 d. (NM: neurogenic medium). Scale bars are shown. *p < 0.05 vs. Con.
Figure 5HERS-H1 cells-derived ELVs activated Wnt/β-Catenin signaling. (A) Immunoblots of exosomal (Hsp70, CD63) and cytoplasmatic cell (actin) markers; Wnt3a proteins in ELVs are presented in the panel. (B) Real time RT-PCR showing the upregulated expression of AXIN2 and TCF7 in DPC cells after treatment with ELVs (80 μg/mL). (C) Western blotting revealing the upregulated expression of β-catenin in DPC cells after treatment with ELVs (80 μg/mL), whereas the same marker was significantly downregulated in the ELVs+DKK1 and DKK1 groups. (D) Immunofluorescence staining of β-catenin in DPC cells after treatment with ELVs (80 μg/mL) alone or combined with DKK1. In the control, β-catenin mostly existed in the cytosol of DPC cells, even after addition of DKK1. ELVs induced the transference of β-catenin from the cytosol into the nucleus (white arrow). Accordingly, addition of DKK1 into ELVs could inhibit the transference of β-catenin from the cytosol into the nucleus. (E) Treatment with ELVs (80 μg/mL) upregulated the expression of DMP1 and DSPP, which was attenuated by treatment with DKK1. (DSPP: dentin sialophosphoprotein; DMP1: dentin matrix protein 1). Scale bars are shown. *p < 0.05 vs. Con; #p < 0.05 vs ELVs.
Figure 6HERS-H1 cells-derived ELVs incorporated collagen gel enhanced cell survival. (A) ELVs within collagen gel were processed for SEM and confocal microscopy (white arrow). (B) The release efficiency of ELVs within the collagen gel was analyzed using the BCA method. (C) DPC cells endocytosed ELVs released from the collagen gel (white arrow). DPC cells were incubated onto collagen gel filled with DiO-labeled ELVs (green) for 2, 24, and 48 h, respectively. Cells were stained with phallotoxins (red) and nuclei were stained with DAPI (blue). (D) Live/dead staining of cultured DPC cells within the ELVs-containing collagen gel. Live cells are labeled with green, whereas red staining indicates dead cells. (E) Death rates of DPC cells within the collagen gel are shown. Scale bars are shown. *p < 0.05 vs. Con.
Figure 7HERS-H1 cells-derived ELVs increased (A) The implanted tooth root slice, with an internal diameter of 2 mm and a height of 3 mm. (B) Schematic of the preparation of in vivo transplants. DPC cells were resuspended with collagen gel mixed with ELVs, and then injected into TDM tubes. (C) HE staining showing odontoblast-like cells and regenerated dentin-like tissue (red arrows) at the interface between the dentin and pulp-like tissue. Immunofluorescence analysis showing the upregulated expression of odontogenic differentiation markers (DSPP and DMP1) in the Gel-ELVs+DPCs group, with positive staining (white arrows) represented by green stains. (DSPP: dentin sialophosphoprotein; DMP1: dentin matrix protein 1; TDM: treated dentin matrix; Rd: regenerated dentin-like tissue; Od: odontoblast-like cell; DP: dental pulp-like tissue). Scale bars are shown.
Figure 8HERS-H1 cells-derived ELVs increased angiopoiesis HE staining showing the newly-formed blood vessels (white arrows). Immunofluorescence showing the increased expression of angiogenic markers (CD31 and VEGF) and neurogenesis markers (MBP101 and NF200) in the Gel-ELVs+DPCs group (white arrows). (TDM: treated dentin matrix; BV: blood vessels; DP: dental pulp-like tissue). Scale bars are shown.